[HTML][HTML] The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis
Background and aim Atrial fibrillation (AF) is the most frequently observed cardiac
arrhythmia in clinical settings. Obesity can influence the efficacy of the treatment …
arrhythmia in clinical settings. Obesity can influence the efficacy of the treatment …
[HTML][HTML] The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis
S Elfar, SA Mahmoud, S Hamdi, AA Emad… - BMC Cardiovascular …, 2024 - ncbi.nlm.nih.gov
Methods We conducted a literature search on PubMed, Web of Science, the Cochrane
Library, and Scopus till October 2022 for articles addressing the efficacy and safety of …
Library, and Scopus till October 2022 for articles addressing the efficacy and safety of …
[HTML][HTML] The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis
S Elfar, SA Mahmoud, S Hamdi… - BMC …, 2024 - bmccardiovascdisord.biomedcentral …
Atrial fibrillation (AF) is the most frequently observed cardiac arrhythmia in clinical settings.
Obesity can influence the efficacy of the treatment administered, which requires a larger …
Obesity can influence the efficacy of the treatment administered, which requires a larger …
The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis.
S Elfar, SA Mahmoud, S Hamdi… - BMC …, 2024 - search.ebscohost.com
Background and aim: Atrial fibrillation (AF) is the most frequently observed cardiac
arrhythmia in clinical settings. Obesity can influence the efficacy of the treatment …
arrhythmia in clinical settings. Obesity can influence the efficacy of the treatment …
The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis
S Elfar, S Mahmoud, S Hamdi, A Emad… - BMC Cardiovascular …, 2024 - europepmc.org
Methods We conducted a literature search on PubMed, Web of Science, the Cochrane
Library, and Scopus till October 2022 for articles addressing the efficacy and safety of …
Library, and Scopus till October 2022 for articles addressing the efficacy and safety of …
The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis
S Elfar, SA Mahmoud, S Hamdi… - BMC …, 2024 - pubmed.ncbi.nlm.nih.gov
Background and aim Atrial fibrillation (AF) is the most frequently observed cardiac
arrhythmia in clinical settings. Obesity can influence the efficacy of the treatment …
arrhythmia in clinical settings. Obesity can influence the efficacy of the treatment …
The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis.
S Elfar, SA Mahmoud, S Hamdi, AA Emad… - BMC Cardiovascular …, 2024 - europepmc.org
Methods We conducted a literature search on PubMed, Web of Science, the Cochrane
Library, and Scopus till October 2022 for articles addressing the efficacy and safety of …
Library, and Scopus till October 2022 for articles addressing the efficacy and safety of …
[PDF][PDF] The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis
S Elfar, SA Mahmoud, S Hamdi, AA Emad… - 2024 - bmccardiovascdisord.biomedcentral …
Background and aim Atrial fibrillation (AF) is the most frequently observed cardiac
arrhythmia in clinical set‑tings. Obesity can influence the efficacy of the treatment …
arrhythmia in clinical set‑tings. Obesity can influence the efficacy of the treatment …